Pharmax breaks ground on pharma production facility at DuBiotech

The new AED40m ($10.8m) manufacturing facility will mark the company’s expansion into growing regional pharmaceutical markets while signalling the first pharmaceutical production unit at DuBiotech.

The90,000ft² facility is as per the US FDA and EU guidelines, in addition to meeting the regulatory standards for Good Manufacturing Facility (GMP) as mandated by the UAE Ministry of Health.

The new factory will produce oral solid dosage products including tablets and capsules for treating conditions such as diabetes, hyperlipidemia, hypertension, peptic ulcers, psychiatric conditions, neurological and respiratory tract disorders.

Pharmax Pharmaceuticals is a wholly-owned subsidiary of Ittihad Drug Store, pharmaceutical distributor in UAE.